| |
| >
|
Publications
- Teuber G, Pascu M, Berg
T, Lafrenz M, Pausch J, Kullmann
F, Ramadori G, Arnold R, Weidenbach
H, Musch E, Junge U, Wiedmann
KH, Herrmann E, Zankel M,
Zeuzem S. Randomized, controlled
trial with IFN-alpha combined
with ribavirin with and without
amantadine sulphate in non-responders
with chronic hepatitis C.
J Hepatol 2003 Oct; 39(4):
606-13.
- Cornberg M, Hinrichsen H,
Teuber G, Berg T, Naumann
U, Falkenberg C, Zeuzem S,
Manns MP. Mycophenolate mofetil
in combination with recombinant
interferon alfa-2a in interferon-nonresponder
patients with chronic hepatitis
C. J Hepatol 2002 Dec; 37(6):
843-7.
- Teuber G, Berg T, Naumann
U, Raedle J, Brinkmann S,
Hopf U, Zeuzem S. Randomized,
placebo-controlled, double-blind
trial with interferon-alpha
with and without amantadine
sulphate in primary interferon-alpha
nonresponders with chronic
hepatitis C. J Viral Hepat
2001 Jul; 8(4): 276-83.
- Zeuzem S, Teuber G, Naumann
U, Berg T, Raedle J, Hartmann
S, Hopf U. Randomized, double-
blind, placebo-controlled
trial of interferon alfa2a
with and without amantadine
as initial treatment for chronic
hepatitis C. Hepatology. 2000
Oct; 32(4 Pt 1): 835-41.
- Sarrazin C, Teuber G, Kokka
R, Rabenau H, Zeuzem S. Detection
of residual hepatitis C virus
RNA by transcription-mediated
amplification in patients
with complete virologic response
according to polymerase chain
reaction-based assays. Hepatology
2000 Oct; 32(4 Pt 1): 818-23.
- Teuber G, Berg T, Hoffmann
RM, Leifeld L, Lafrenz M,
Spengler U, Pape GR, Hopf
U, Zeuzem S. Retreatment with
interferon-alpha and ribavirin
in primary interferon-alpha
non-responders with chronic
hepatitis C. Digestion 2000;
61(2): 90-7.
|
|
